
Shockwave Medical, Inc. (Nasdaq: SWAV), relating to its proposed sale to Johnson & Johnson. Under the terms of the agreement, SWAV shareholders are expected to receive $335.00 in cash per share they own.
Shockwave Medical, Inc. (Nasdaq: SWAV), relating to its proposed sale to Johnson & Johnson. Under the terms of the agreement, SWAV shareholders are expected to receive $335.00 in cash per share they own.